The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 

This appendix has been provided by the authors to give readers additional information about their work.

Supplement to: Walsh P, DeWeese TL, and Eisenberger MA. Localized Prostate Cancer. N Engl J Med 2007;357(26):2696-705.

Han Tables

1. Preoperative model (for men who are considering surgery for prostate cancer, but have not had surgery yet)

Prediction of the probability of recurrence after surgery with the use of the available information before the surgery (prostate-specific antigen [PSA] level, Gleason score of the biopsy specimen, and clinical stage)

On the basis of the PSA, Gleason score, and clinical stage, the recurrence probability is calculated at 3, 5, 7, and 10 years after surgery

Select:

PSA:       Gleason Score:       Clinical Stage:

2. Postoperative model (for men who have had surgery for prostate cancer)

Prediction of the probability of recurrence after surgery with the use of the available information before and after the surgery (PSA level, Gleason score of the adenocarcinoma removed during surgery, and pathological stage)

On the basis of the PSA, Gleason score, and pathological stage, the probability of recurrence is calculated at 3, 5, 7, and 10 years after surgery

Select:

PSA:       Gleason Score:

Pathological Stage:

See also: Partin Tables.

Return to main article.


HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.